| AEREA Y POSTAL EX-IAAC | 2025 | 12.338 | KG | TEPADINA 100 mg, THIOTEPA, S/M TEPADINA 100 mg / Scientific name: Thiotepa for Injection PRODUCTO: 410000104 / BATCH : 24T122 / EXPIRY DATE: 06-2027 PARA TRATAMIENTO DE CANCER DE OVARIO RECURRENTE RECETA: 4865/2025 | SWITZERLAND | SWITZERLAND | 9337.22 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.352 | KG | ZANUBRUTINIB, S/M, S/M ZANUBRUTINIB BRUKINSA 80MG 120 CAP BEIGENE LOTE; 1000024436 / 80MG (120 CAPSULAS) PARA COMBATIR MACROGLOBOLINEMIA DE WALDESTROM RECETA: 6696/2024 | GERMANY | SPAIN | 5454.86 |
| AEREA Y POSTAL EX-IAAC | 2025 | 9.405 | KG | MIRVETUXIMAB SORAVTANSINE, S/M, S/M MIRVETUXIMAB SORAVTANSINE ELAHERE 5 MG/ML PRODUCTO: 19448080 PARA CANCER DE OVARIO RECURRENTE RECETA: 1956/2025 | GERMANY | GERMANY | 49221.1 |
| AEREA Y POSTAL EX-IAAC | 2025 | 9.78 | KG | METHOXSALEN, UVADEX, S/M 1002946/ UVADEX - METHOXSALEN - 20 MCG/ML - SOLUTION FOR BLOOD FRACTION MODIFICATION 12 X 10 ML - GB - PL 42956/0001 (UVA501) // LOTE: AV4316 - EXP: 30/04/2027 PARA TRATAMIENTO DE PACIENTE CON LEUCEMIA LINFOBLASTICA AGUDA R | UNITED KINGDOM | UNITED STATES | 3031.61 |
| AEREA Y POSTAL EX-IAAC | 2025 | 9.5 | KG | METHOXSALEN, UVADEX, S/M 1002946/ UVADEX - METHOXSALEN - 20 MCG/ML - SOLUTION FOR BLOOD FRACTION MODIFICATION 12 X 10 ML - GB - PL 42956/0001 (UVA501) // LOTE: AV4316 - EXP: 30/04/2027 PARA TRATAMIENTO DE PACIENTE RECETA: 8773/2025 - FABRICANTE: T | UNITED KINGDOM | UNITED KINGDOM | 3053.18 |
| AEREA Y POSTAL EX-IAAC | 2025 | 1.786 | KG | ASPARAGINASA PEGILADA, S/M, S/M ASPARAGINASA PEGILADA ONCASPAR 3750 UNITS PII - POWDER FOR SOLUTION FOR INJECTION/INFUSION CONCENTRACION: 3750 IU/5ML, PRESENTACION: VIAL PARA USO ONCOLOGICO - PARA PACIENTE CON DIAGNOSTICO DE LEUCEMIA RECETA: 1217/202 | IRAN, ISLAMIC REPUBLIC OF | GERMANY | 1716.43 |
| AEREA Y POSTAL EX-IAAC | 2025 | 3.628 | KG | MELFALAN (ALKERAN), ASPEN, S/M (MELFALAN) ALKERAN*EV 1FL 50MG+1F 10ML ITEM: 021250028 PRODUCTOS DE DIAGNOSTICO MEDICO RECETA: 319/2025 4346/2025 4051/2025 3861/2024 2977/2024 | ITALY | ITALY | 2078.98 |
| AEREA Y POSTAL EX-IAAC | 2025 | 10.185 | KG | NAXITAMAB DANYELZA, S/M, S/M NAXITAMAB DANYELZA 40MG 1FCO NPP CODIGO: 951816 // LOTE: AW2713BAC - EXP: 31/05/2026 GRUPO FARMACOTERAPEUTICO: AGENTE ANTINEOPLASTICO E INMUNOMODULADORES RECETA: 9988/2025 | UNITED STATES | URUGUAY | 26700 |
| AEREA Y POSTAL EX-IAAC | 2025 | 9.017 | KG | DANYELZA, S/M, S/M NAXITAMAB DANYELZA 40MG 1FCO NPP CODIGO: 951816 // LOTE: AU9721-01 EXP: 30/09/2026 GRUPO FARMACOTERAPEUTICO: AGENTE ANTINEOPLASTICO E INMUNOMODULADORES RECETA: | UNITED STATES | URUGUAY | 106800 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.673 | KG | SAGRAMOSTIN LEUKINE, S/M, S/M SAGRAMOSTIM LEUKINE 250 MCG VL 5 AMP 1 ML CODIGO: 951885 // LOTE: B27888A EXP: 30/11/2027 GRUPO FARMACOTERAPEUTICO: AGENTE ANTINEOPLASTICO E INMUNOMODULADORES RECETA: 1783/2025 | UNITED STATES | URUGUAY | 7965 |
| AEREA Y POSTAL EX-IAAC | 2025 | 9.017 | KG | NAXITAMAB DANYELZA, S/M, S/M NAXITAMAB DANYELZA 40MG 1FCO NPP CODIGO: 951816 // LOTE: AU9721-01 EXP: 30/09/2026 GRUPO FARMACOTERAPEUTICO: AGENTE ANTINEOPLASTICO E INMUNOMODULADORES RECETA: 1783/2025 | UNITED STATES | URUGUAY | 106800 |
| AEREA Y POSTAL EX-IAAC | 2025 | 9.5 | KG | ASPARAGINASA PEGILADA ONCASPAR, S/M, S/M ASPARAGINASA PEGILADA ONCASPAR 3.750 I/U, 1 VIAL CONCENTRACION: 3750 IU/5ML, PRESENTACION: VIAL PARA USO ONCOLOGICO - RECETA: 1217/2025 (PHARMACEUTICALS) MANUFACTURER - EXELEAD BATCH: 3222K - EXPIRY: 30.04.202 | UNITED STATES | GERMANY | 8113.91 |
